Wolverine Trading’s Orthofix Medical OFIX Stock Holding History

Wolverine Trading’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-6,100	Closed	-$323K	–	4826
2019 Q2	$323K	Sell	6,100 -9,600	-61%	-$511K	﹤0.01%	3190
2019 Q1	$886K	Buy	15,700 +6,900	+78%	+$387K	﹤0.01%	2196
2018 Q4	$462K	Buy	+8,800	New	+$501K	﹤0.01%	2713
2017 Q2	–	Sell	-5,900	Closed	-$226K	–	4764
2017 Q1	$226K	Buy	+5,900	New	+$218K	﹤0.01%	3369

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wolverine Trading's OFIX Position: Q2 2019 in Review

Wolverine Trading sold out of Orthofix Medical (OFIX) in Q2 2019, closing a stake of 5,131 shares — an estimated $273K sold.

Wolverine Trading first reported a position in OFIX in Q1 2019 and held it in 1 quarter. The position peaked at $289K in Q1 2019. 157 funds tracked by Wall St. Rank hold OFIX as of Q2 2019.

Wolverine Trading reported no remaining Orthofix Medical position as of Q2 2019 after selling out during the quarter.
Wolverine Trading sold 5,131 Orthofix Medical shares in Q2 2019, an estimated $273K.
Wolverine Trading first reported a position in Orthofix Medical in Q1 2019 and held it in 1 quarter.
Wolverine Trading's Orthofix Medical position peaked at $289K in Q1 2019.
157 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2019.

Based on Wolverine Trading's 13F filing for Q2 2019, filed 20 Aug 2019.